Table 1. Snapshot of North America Clinical Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in North America Clinical Diagnostics Market 33
Table 5. North America Clinical Diagnostics Market by Test, 2021-2031, $ mn 41
Table 6. North America Clinical Diagnostics Market by Product, 2021-2031, $ mn 50
Table 7. North America Clinical Diagnostics Market by Indication, 2021-2031, $ mn 55
Table 8. North America Clinical Diagnostics Market by Patient Gender, 2021-2031, $ mn 64
Table 9. North America Clinical Diagnostics Market by Age Group, 2021-2031, $ mn 68
Table 10. North America Clinical Diagnostics Market by End User, 2021-2031, $ mn 73
Table 11. North America Clinical Diagnostics Market by Country, 2021-2031, $ mn 80
Table 12. U.S. Clinical Diagnostics Market by Test, 2021-2031, $ mn 85
Table 13. U.S. Clinical Diagnostics Market by Product, 2021-2031, $ mn 85
Table 14. U.S. Clinical Diagnostics Market by Indication, 2021-2031, $ mn 85
Table 15. Canada Clinical Diagnostics Market by Test, 2021-2031, $ mn 87
Table 16. Canada Clinical Diagnostics Market by Product, 2021-2031, $ mn 87
Table 17. Canada Clinical Diagnostics Market by Indication, 2021-2031, $ mn 87
Table 18. Mexico Clinical Diagnostics Market by Test, 2021-2031, $ mn 89
Table 19. Mexico Clinical Diagnostics Market by Product, 2021-2031, $ mn 89
Table 20. Mexico Clinical Diagnostics Market by Indication, 2021-2031, $ mn 89
Table 21. Abbott Laboratories: Company Snapshot 94
Table 22. Abbott Laboratories: Business Segmentation 95
Table 23. Abbott Laboratories: Product Portfolio 95

LIST OF FIGURE

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. North America Clinical Diagnostics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of North America Clinical Diagnostics Market 24
Figure 7. Leading Causes of Death in the World, 2019-2020, million 27
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 10. Primary Restraints and Impact Factors of North America Clinical Diagnostics Market 30
Figure 11. Investment Opportunity Analysis 34
Figure 12. Porters Fiver Forces Analysis of North America Clinical Diagnostics Market 37
Figure 13. Breakdown of North America Clinical Diagnostics Market by Test, 2021-2031, % of Revenue 42
Figure 14. North America Addressable Market Cap in 2022-2031 by Test, Value ($ mn) and Share (%) 42
Figure 15. North America Clinical Diagnostics Market by Test: Lipid Panel, 2021-2031, $ mn 43
Figure 16. North America Clinical Diagnostics Market by Test: Infectious Disease Testing, 2021-2031, $ mn 44
Figure 17. North America Clinical Diagnostics Market by Test: Liver Panel, 2021-2031, $ mn 45
Figure 18. North America Clinical Diagnostics Market by Test: Complete Blood Count (CBC), 2021-2031, $ mn 46
Figure 19. North America Clinical Diagnostics Market by Test: Electrolyte Testing, 2021-2031, $ mn 47
Figure 20. North America Clinical Diagnostics Market by Test: Renal Panel, 2021-2031, $ mn 48
Figure 21. North America Clinical Diagnostics Market by Test: Other Tests, 2021-2031, $ mn 49
Figure 22. Breakdown of North America Clinical Diagnostics Market by Product, 2021-2031, % of Sales Revenue 51
Figure 23. North America Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 51
Figure 24. North America Clinical Diagnostics Market by Product: Instruments, 2021-2031, $ mn 52
Figure 25. North America Clinical Diagnostics Market by Product: Assay Kits & Reagents, 2021-2031, $ mn 53
Figure 26. North America Clinical Diagnostics Market by Product: Software & Services, 2021-2031, $ mn 54
Figure 27. Breakdown of North America Clinical Diagnostics Market by Indication, 2021-2031, % of Sales Revenue 56
Figure 28. North America Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 56
Figure 29. North America Clinical Diagnostics Market by Indication: Cardiovascular, 2021-2031, $ mn 57
Figure 30. North America Clinical Diagnostics Market by Indication: Cancer, 2021-2031, $ mn 58
Figure 31. North America Clinical Diagnostics Market by Indication: Infectious Disease, 2021-2031, $ mn 59
Figure 32. North America Clinical Diagnostics Market by Indication: Stroke, 2021-2031, $ mn 60
Figure 33. North America Clinical Diagnostics Market by Indication: Chronic Lower Respiratory Diseases, 2021-2031, $ mn 61
Figure 34. North America Clinical Diagnostics Market by Indication: Diabetes, 2021-2031, $ mn 62
Figure 35. North America Clinical Diagnostics Market by Indication: Other Indications, 2021-2031, $ mn 63
Figure 36. Breakdown of North America Clinical Diagnostics Market by Patient Gender, 2021-2031, % of Revenue 65
Figure 37. North America Addressable Market Cap in 2022-2031 by Patient Gender, Value ($ mn) and Share (%) 65
Figure 38. North America Clinical Diagnostics Market by Patient Gender: Male Patients, 2021-2031, $ mn 66
Figure 39. North America Clinical Diagnostics Market by Patient Gender: Female Patients, 2021-2031, $ mn 67
Figure 40. Breakdown of North America Clinical Diagnostics Market by Age Group, 2021-2031, % of Revenue 69
Figure 41. North America Addressable Market Cap in 2022-2031 by Age Group, Value ($ mn) and Share (%) 69
Figure 42. North America Clinical Diagnostics Market by Age Group: Age 44 and below, 2021-2031, $ mn 70
Figure 43. North America Clinical Diagnostics Market by Age Group: Age 45-64, 2021-2031, $ mn 71
Figure 44. North America Clinical Diagnostics Market by Age Group: Age 65 and over, 2021-2031, $ mn 72
Figure 45. Breakdown of North America Clinical Diagnostics Market by End User, 2021-2031, % of Revenue 73
Figure 46. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 74
Figure 47. North America Clinical Diagnostics Market by End User: Hospital & Clinics Laboratory, 2021-2031, $ mn 75
Figure 48. North America Clinical Diagnostics Market by End User: Diagnostic Laboratory, 2021-2031, $ mn 76
Figure 49. North America Clinical Diagnostics Market by End User: Point-of-Care Testing, 2021-2031, $ mn 77
Figure 50. North America Clinical Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 78
Figure 51. Breakdown of North America Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 80
Figure 52. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 81
Figure 53. U.S. Clinical Diagnostics Market, 2021-2031, $ mn 83
Figure 54. Percent Distribution of the 10 Leading Causes of Death by Gender in United States, 2019, % 83
Figure 55. Percent Distribution of the 10 Leading Causes of Death by Age Group in United States, 2019, % 84
Figure 56. Canada Clinical Diagnostics Market, 2021-2031, $ mn 86
Figure 57. Clinical Diagnostics Market in Mexico, 2021-2031, $ mn 88
Figure 58. Growth Stage of North America Clinical Diagnostics Industry over the Forecast Period 90